Skip to Content
Merck
All Photos(2)

Key Documents

View All Documentation

Safety Information

V900357

Sigma-Aldrich

Sodium 1-heptanesulfonate

Vetec™, reagent grade

Synonym(s):

1-Heptanesulfonic acid sodium salt

Sign Into View Organizational & Contract Pricing
All Photos(2)

About This Item

Linear Formula:
C7H15O3SNa
CAS Number:
22767-50-6
Molecular Weight:
202.25
EC Number:
245-210-5
MDL number:
MFCD00007543
UNSPSC Code:
12161900
PubChem Substance ID:
329829769

grade

reagent grade

product line

Vetec™

mol wt

202.25 g/mol

technique(s)

UV/Vis spectroscopy: suitable

SMILES string

[Na+].CCCCCCCS([O-])(=O)=O

InChI

1S/C7H16O3S.Na/c1-2-3-4-5-6-7-11(8,9)10;/h2-7H2,1H3,(H,8,9,10);/q;+1/p-1

InChI key

REFMEZARFCPESH-UHFFFAOYSA-M

Looking for similar products? Visit Product Comparison Guide

Application

Ion-pairing reagent for HPLC, including analyses of peptides and proteins.

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class Code

11 - Combustible Solids

WGK

WGK 2

Regulatory Listings

Regulatory Listings are mainly provided for chemical products. Only limited information can be provided here for non-chemical products. No entry means none of the components are listed. It is the user’s obligation to ensure the safe and legal use of the product.

JAN Code

V900357-VAR:
V900357-BULK:
V900357-25G:

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
WXBD6907V
WXBC9514V
WXBC4891V
WXBB1556V
SHBC2536V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Takeshi Oshizaka et al.
International journal of pharmaceutics, 475(1-2), 292-297 (2014-08-27)
Skin concentrations of topically administered compounds need to be considered in order to evaluate their efficacies and toxicities. This study investigated the relationship between the skin permeation and concentrations of compounds, and also predicted the skin concentrations of these compounds
Marianna Sikorska et al.
Neurobiology of aging, 35(10), 2329-2346 (2014-04-30)
Although the support for the use of antioxidants, such as coenzyme Q(10) (CoQ(10)), to treat Parkinson's disease (PD) comes from the extensive scientific evidence, the results of conducted thus far clinical trials are inconclusive. It is assumed that the efficacy
Jie Ma et al.
Pharmacology, 93(5-6), 220-224 (2014-07-12)
It is significant for patients with traumatic brain injury (TBI) to receive prehospital emergency treatment as early as possible to reduce mortality. Therefore, a new prefilled multi-drug injector was developed to improve the treatment of TBI. Here, we studied the
Miriam Dadparvar et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 88(2), 510-517 (2014-07-06)
Severe intoxications with organophosphates require the immediate administration of atropine in combination with acetyl cholinesterase (AChE) reactivators such as HI-6. Although this therapy regimen enables the treatment of peripheral symptoms, the blood-brain barrier (BBB) restricts the access of the hydrophilic
Erina Kitagawa et al.
Bioscience, biotechnology, and biochemistry, 79(8), 1320-1326 (2015-03-18)
We investigated the efficacy of supplementing the diet with pteroylmonoglutamic acid (PGA), choline, or phosphatidylcholine (PC) in ameliorating the lipid accumulation in rat liver that is induced by vitamin B6 (B6) deficiency. In Experiment 1, male Wistar rats were fed
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service